Skip Navigation
NCI banner National Cancer Institute U.S. National Institutes of Health National Cancer Institute
Chromosomes
  • Tools
  • Genetic and Physical SNP Maps
  • SNP500Cancer
Cancer Genome Characterization Initiative

Visit the database of genomic characterization data for multiple tumor types.

Association List

Go to page: 1 2 [Full Text] NextPage
Displaying Investigations 1 to 100 of 104 found
From 8 References


Frattini et al 2013, Nat Genet
  Astrocytoma, grade III-IV/Glioblastoma Brain
POLR2A/WRAP53
t(17;17)(p13;p13)
  Astrocytoma, grade III-IV/Glioblastoma Brain
SENP3/GPS2
t(17;17)(p13;p13)

Hu et al 2018, Nucleic Acids Res
  Transitional cell carcinoma Bladder
ABR/RTN4RL1
t(17;17)(p13;p13)
  Malignant melanoma Skin
C17orf85/ATP2A3
t(17;17)(p13;p13)
  Adenocarcinoma Ovary
CLDN7/TMEM256
t(17;17)(p13;p13)
  Squamous cell carcinoma Lung
CRK/STX8
t(17;17)(p13;p13)
  Adenocarcinoma Oesophagus
DLG4/GAS7
t(17;17)(p13;p13)
  Embryonal nervous system tumor, special type Adrenal
DPH1/RPA1
t(17;17)(p13;p13)
  Germ cell tumor, NOS Testis
FXR2/TP53
t(17;17)(p13;p13)
  Adenocarcinoma Gallbladder/Biliary system
INPP5K/RPA1
t(17;17)(p13;p13)
  Adenocarcinoma Breast
KDM6B/TMEM95
t(17;17)(p13;p13)
  Adenocarcinoma Prostate
KIF1C/NDEL1
t(17;17)(p13;p13)
  Transitional cell carcinoma Bladder
KRBA2/YBX2
t(17;17)(p13;p13)
  Mesenchymal tumor, NOS Unknown site
METTL16/FXR2
t(17;17)(p13;p13)
  Mesenchymal tumor, NOS Unknown site
METTL16/CLEC10A
t(17;17)(p13;p13)
  Squamous cell carcinoma Unknown site
MINK1/ALOX12
t(17;17)(p13;p13)
  Adenocarcinoma Stomach
MINK1/SPNS3
t(17;17)(p13;p13)
  Mesenchymal tumor, NOS Unknown site
MPDU1/SPEM1
t(17;17)(p13;p13)
  Adenocarcinoma Prostate
MPDU1/GLP2R
t(17;17)(p13;p13)
  Squamous cell carcinoma Lung
MYBBP1A/FGF11
t(17;17)(p13;p13)
  Adenocarcinoma Uterus, corpus
MYH10/CCDC42
t(17;17)(p13;p13)
  Squamous cell carcinoma Lung
MYO1C/SMG6
t(17;17)(p13;p13)
  Adenocarcinoma Uterus, corpus
MYO1C/SMTNL2
t(17;17)(p13;p13)
  Astrocytoma, grade I-II Brain
NDEL1/CHD3
t(17;17)(p13;p13)
  Mesenchymal tumor, NOS Unknown site
NEURL4/SOX15
t(17;17)(p13;p13)
  Transitional cell carcinoma Bladder
NUP88/NLRP1
t(17;17)(p13;p13)
  Adenocarcinoma Uterus, corpus
NXN/SLC43A2
t(17;17)(p13;p13)
  Malignant melanoma Skin
PAFAH1B1/CTDNEP1
t(17;17)(p13;p13)
  Malignant melanoma Skin
PAFAH1B1/ABR
t(17;17)(p13;p13)
  Adenocarcinoma Kidney
PITPNA/SLC43A2
t(17;17)(p13;p13)
  Adenocarcinoma Gallbladder/Biliary system
PITPNM3/P2RX5
t(17;17)(p13;p13)
  Adenocarcinoma Breast
PLD2/ZZEF1
t(17;17)(p13;p13)
  Adenocarcinoma Oesophagus
RABEP1/ZFP3
t(17;17)(p13;p13)
  Squamous cell carcinoma Unknown site
RABEP1/RNF167
t(17;17)(p13;p13)
  Adenocarcinoma Gallbladder/Biliary system
RNMTL1/ALOX15B
t(17;17)(p13;p13)
  Adenocarcinoma Gallbladder/Biliary system
RPA1/WDR81
t(17;17)(p13;p13)
  Mesenchymal tumor, NOS Unknown site
RPAIN/STX8
t(17;17)(p13;p13)
  Adenocarcinoma Large intestine
SENP3/ABR
t(17;17)(p13;p13)
  Squamous cell carcinoma Uterus, cervix
SGSM2/SRR
t(17;17)(p13;p13)
  Adenocarcinoma Breast
SHPK/ATP2A3
t(17;17)(p13;p13)
  Adenocarcinoma Uterus, corpus
SLC43A2/SMYD4
t(17;17)(p13;p13)
  Adenocarcinoma Pancreas
SMG6/VPS53
t(17;17)(p13;p13)
  Adenocarcinoma Prostate
SMG6/SHPK
t(17;17)(p13;p13)
  Adenocarcinoma Prostate
SMG6/ANKFY1
t(17;17)(p13;p13)
  Adenocarcinoma Uterus, corpus
SMYD4/TUSC5
t(17;17)(p13;p13)
  Adenocarcinoma Stomach
SMYD4/SERPINF1
t(17;17)(p13;p13)
  Malignant melanoma Skin
TP53/CHD3
t(17;17)(p13;p13)
  Adenocarcinoma Prostate
TP53/KIAA0753
t(17;17)(p13;p13)
  Adenocarcinoma Uterus, corpus
TRPV3/UBE2G1
t(17;17)(p13;p13)
  Malignant melanoma Skin
TXNDC17/YBX2
t(17;17)(p13;p13)
  Squamous cell carcinoma Lung
WDR81/CYB5D1
t(17;17)(p13;p13)
  Mesenchymal tumor, NOS Unknown site
VPS53/TXNDC17
t(17;17)(p13;p13)
  Adenocarcinoma Liver
VPS53/SMG6
t(17;17)(p13;p13)
  Squamous cell carcinoma Unknown site
VPS53/ABR
t(17;17)(p13;p13)
  Adenocarcinoma Kidney
WSCD1/NLRP1
t(17;17)(p13;p13)
  Adenocarcinoma Large intestine
YWHAE/INPP5K
t(17;17)(p13;p13)
  Adenocarcinoma Large intestine
YWHAE/PITPNA
t(17;17)(p13;p13)
  Malignant epithelial tumor, special type Uterus, corpus
ZFP3/ARRB2
t(17;17)(p13;p13)
  Adenocarcinoma Breast
ZNF594/SCIMP
t(17;17)(p13;p13)

McPherson et al 2011, PLoS Comput Biol
  Adenocarcinoma Ovary
CYB5D2/ANKFY1
t(17;17)(p13;p13)

Robinson et al 2017, Nature
  Adenocarcinoma Prostate
TP53/SMYD4
t(17;17)(p13;p13)
  Adenocarcinoma Prostate
TP53/MYBBP1A
t(17;17)(p13;p13)
  Adenocarcinoma Prostate
KDM6B/TP53
t(17;17)(p13;p13)

Seo et al 2012, Genome Res
  Adenocarcinoma Lung
XAF1/FAM64A
t(17;17)(p13;p13)

Warren et al 2017, Cancer Genet
  Aneurysmal bone cyst Skeleton
PAFAH1B1/USP6
t(17;17)(p13;p13)

Yang et al 2015, J Genet Genomics
  Squamous cell carcinoma Lung
YWHAE/CRK
t(17;17)(p13;p13)

Yoshihara et al 2015, Oncogene
  Adenocarcinoma Prostate
RABEP1/MINK1
t(17;17)(p13;p13)
  Adenocarcinoma Prostate
SMG6/DHX33
t(17;17)(p13;p13)
  Adenocarcinoma Prostate
MPDU1/CTDNEP1
t(17;17)(p13;p13)
  Adenocarcinoma Ovary
PITPNA/PRPF8
t(17;17)(p13;p13)
  Squamous cell carcinoma Lung
ABR/GAS7
t(17;17)(p13;p13)
  Squamous cell carcinoma Lung
TAX1BP3/C17orf85
t(17;17)(p13;p13)
  Squamous cell carcinoma Lung
NTN1/STX8
t(17;17)(p13;p13)
  Squamous cell carcinoma Lung
SPAG7/CAMTA2
t(17;17)(p13;p13)
  Adenocarcinoma Lung
GAS7/MYH1
t(17;17)(p13;p13)
  Squamous cell carcinoma Lung
RNF167/PLD2
t(17;17)(p13;p13)
  Adenocarcinoma Lung
VPS53/ZZEF1
t(17;17)(p13;p13)
  Adenocarcinoma Lung
YWHAE/SLC43A2
t(17;17)(p13;p13)
  Adenocarcinoma Lung
NXN/ABR
t(17;17)(p13;p13)
  Adenocarcinoma Lung
KDM6B/DNAH2
t(17;17)(p13;p13)
  Adenocarcinoma Lung
ABR/CRK
t(17;17)(p13;p13)
  Adenocarcinoma Lung
TMEM107/WRAP53
t(17;17)(p13;p13)
  Astrocytoma, grade I-II Brain
ABR/YWHAE
t(17;17)(p13;p13)
  Astrocytoma, grade I-II Brain
VPS53/GLOD4
t(17;17)(p13;p13)
  Adenocarcinoma Kidney
NDEL1/WSCD1
t(17;17)(p13;p13)
  Adenocarcinoma Kidney
PITPNM3/STX8
t(17;17)(p13;p13)
  Adenocarcinoma Kidney
ZZEF1/ANKFY1
t(17;17)(p13;p13)
  Squamous cell carcinoma Oral cavity
NXN/WRAP53
t(17;17)(p13;p13)
  Adenocarcinoma Breast
VPS53/RTN4RL1
t(17;17)(p13;p13)
  Adenocarcinoma Breast
CXCL16/TEKT1
t(17;17)(p13;p13)
  Adenocarcinoma Breast
C17orf85/CAMKK1
t(17;17)(p13;p13)
  Adenocarcinoma Breast
VPS53/MYH2
t(17;17)(p13;p13)
  Adenocarcinoma Breast
AURKB/MYH10
t(17;17)(p13;p13)
  Adenocarcinoma Breast
ZNF594/SCIMP
t(17;17)(p13;p13)
  Adenocarcinoma Breast
SLC43A2/SCARF1
t(17;17)(p13;p13)
  Adenocarcinoma Breast
ABR/PITPNA
t(17;17)(p13;p13)
  Adenocarcinoma Breast
RABEP1/NUP88
t(17;17)(p13;p13)
  Adenocarcinoma Breast
ABR/CLUH
t(17;17)(p13;p13)
  Adenocarcinoma Breast
SLC43A2/SMG6
t(17;17)(p13;p13)
  Adenocarcinoma Breast
SLC35G6/SLC16A13
t(17;17)(p13;p13)

NextPage